Researchers say a new drug for breast cancer will give patients vital extra time.
The drug called Kadcyla was trialled in Manchester and is now available to patients for the first time.
Doctors say it can extend women's lives by almost six months for those with the most aggressive form of the disease.
Around thirteen hundred women in England could benefit from the drug, which costs £6,000 a month.
Mel Barham reports
More top news
Drivers on the M60 will be able to benefit from wider lanes in time for the bank holiday weekend.
A series of outdoor creations will form Chester Zoo's first ever large-scale gardens and science festival this summer.
Cloudier skies overnight into Friday with heavy and possibly thundery downpours